Amarin Corporation (AMRN)
Create an Alert
6.50
-0.10 -1.52%
NASDAQ
Jun 19, 12:06PM
BATS Real time
Currency in USD
Amarin Corporation Cash from Investing Quarterly:
-0.014M for March 31, 2013Amarin Corporation Historical Cash from Investing Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -0.014M |
| Dec. 31, 2012 | -12.63M |
| Sept. 30, 2012 | -0.626M |
| June 30, 2012 | -0.997M |
| March 31, 2012 | -0.092M |
| Dec. 31, 2011 | -0.365M |
| Sept. 30, 2011 | -1.674M |
| June 30, 2011 | -0.009M |
| March 31, 2011 | 0.00 |
| Dec. 31, 2010 | 0.001M |
| Sept. 30, 2010 | 0.00 |
| June 30, 2010 | -0.006M |
| March 31, 2010 | -0.018M |
| June 30, 2009 | -0.06M |
About Cash From Investing
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More
AMRN Cash from Investing Quarterly Benchmarks
| Companies | |
|---|---|
| Omthera Pharmaceuticals | |
| Keryx Biopharmaceuticals | -0.005M |
| Actavis | -171.60M |
AMRN Cash from Investing Quarterly Rankings
| Overall |
83rd percentile 2780 of 16782 |
| Sector |
74th percentile 360 of 1410 in Healthcare |
| Industry |
80th percentile 29 of 152 in Drug Manufacturers - Specialty & Generic |
AMRN Cash from Investing Quarterly Range, Past 5 Years
| Minimum | -12.63M | Dec 2012 |
| Maximum | 0.0690M | Jun 2008 |
| Average | -1.095M |
